Drugs / Venoferrum
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00802139 | Feb 2008 → Jun 2009 | iron deficiency anemia | JW Pharmaceutical | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2019-05-31 | JW Pharmaceutical | Results [JW중외제약] ‘페린젝트’ 월경과다 치료법에 주목 jw-pharma.co.kr ↗
이번 임상시험에서 ‘페린젝트’ 투여군은 월경과다 환자의 수술 전 철 결핍성 빈혈 교정에 있어, ‘Iron Sucrose’ 제제를 투여 받은 대조군과 비교해 빠른 효과와 투약 편의성을 확인했다. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2019-05-31 | JW Pharmaceutical | [JW중외제약] ‘페린젝트’ 월경과다 치료법에 주목 jw-pharma.co.kr ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Venoferrum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00802139 ↗ |
| Known as | iron sucrose | “Drug: venoferrum(iron sucrose)” NCT00802139 ↗ |
| Route | Intravenous | “Intravenous Iron Sucrose (Venoferrum®)” NCT00802139 ↗ |